NO991593D0 - Hormonpreparat bestÕende av en °strogenforbindelse og en progesteronforbindelse - Google Patents

Hormonpreparat bestÕende av en °strogenforbindelse og en progesteronforbindelse

Info

Publication number
NO991593D0
NO991593D0 NO991593A NO991593A NO991593D0 NO 991593 D0 NO991593 D0 NO 991593D0 NO 991593 A NO991593 A NO 991593A NO 991593 A NO991593 A NO 991593A NO 991593 D0 NO991593 D0 NO 991593D0
Authority
NO
Norway
Prior art keywords
compound
progesterone
preparation consisting
estrogen
hormone preparation
Prior art date
Application number
NO991593A
Other languages
English (en)
Other versions
NO991593L (no
NO324357B1 (no
Inventor
Michel Lanquetin
Jacques Paris
Jean-Louis Thomas
Original Assignee
Theramex
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9496456&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO991593(D0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Theramex filed Critical Theramex
Publication of NO991593D0 publication Critical patent/NO991593D0/no
Publication of NO991593L publication Critical patent/NO991593L/no
Publication of NO324357B1 publication Critical patent/NO324357B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/26—Androgens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/811—Drug, bio-affecting and body treating compositions involving sex selection or contraception

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)
NO19991593A 1996-10-08 1999-03-31 Anvendelse av et ostroprogestagenhormonpreparat ved fremstillingen av et medikament for behandling av ostrogenforstyrrelser og osteoporose hos postmenopausale kvinner, samt anvendelse av et farmasoytisk preparat ved fremstilling av et medikament for a stoppe ovulasjon NO324357B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9612239A FR2754179B1 (fr) 1996-10-08 1996-10-08 Nouvelle composition hormononale et son utilisation
PCT/FR1997/001792 WO1998015279A1 (fr) 1996-10-08 1997-10-08 Composition hormonale constituee d'un compose estrogene et d'un compose progestatif

Publications (3)

Publication Number Publication Date
NO991593D0 true NO991593D0 (no) 1999-03-31
NO991593L NO991593L (no) 1999-06-07
NO324357B1 NO324357B1 (no) 2007-10-01

Family

ID=9496456

Family Applications (3)

Application Number Title Priority Date Filing Date
NO19991593A NO324357B1 (no) 1996-10-08 1999-03-31 Anvendelse av et ostroprogestagenhormonpreparat ved fremstillingen av et medikament for behandling av ostrogenforstyrrelser og osteoporose hos postmenopausale kvinner, samt anvendelse av et farmasoytisk preparat ved fremstilling av et medikament for a stoppe ovulasjon
NO2012002C NO2012002I2 (no) 1996-10-08 2012-01-24 Nomegestrolacetat + fritt eller esterifisert østradiol
NO2017043C NO2017043I2 (no) 1996-10-08 2017-08-08 Nomegestrolacetat + fritt eller esterifisert østradiol - forlenget SPC

Family Applications After (2)

Application Number Title Priority Date Filing Date
NO2012002C NO2012002I2 (no) 1996-10-08 2012-01-24 Nomegestrolacetat + fritt eller esterifisert østradiol
NO2017043C NO2017043I2 (no) 1996-10-08 2017-08-08 Nomegestrolacetat + fritt eller esterifisert østradiol - forlenget SPC

Country Status (38)

Country Link
US (4) US6831073B1 (no)
EP (2) EP0956022B1 (no)
JP (1) JP4883542B2 (no)
KR (2) KR20000048981A (no)
CN (3) CN101229173A (no)
AP (1) AP1171A (no)
AR (2) AR009113A1 (no)
AT (2) ATE353652T1 (no)
AU (1) AU745571B2 (no)
BR (1) BR9712274A (no)
CA (1) CA2268358C (no)
CL (1) CL2011000017A1 (no)
CZ (1) CZ298402B6 (no)
DE (3) DE69737373T2 (no)
DK (2) DK1334725T3 (no)
DZ (1) DZ2327A1 (no)
ES (2) ES2198006T3 (no)
FR (2) FR2754179B1 (no)
HK (1) HK1210708A1 (no)
HU (2) HU227450B1 (no)
ID (1) ID21569A (no)
IL (1) IL129194A (no)
LU (1) LU91932I2 (no)
MA (1) MA24370A1 (no)
MY (1) MY128482A (no)
NO (3) NO324357B1 (no)
NZ (1) NZ334876A (no)
OA (1) OA11033A (no)
PL (1) PL192979B1 (no)
PT (2) PT956022E (no)
RU (1) RU2274450C2 (no)
SK (2) SK285455B6 (no)
TN (1) TNSN97164A1 (no)
TR (1) TR199900764T2 (no)
TW (1) TW491704B (no)
WO (1) WO1998015279A1 (no)
YU (1) YU18099A (no)
ZA (1) ZA979011B (no)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4344462C2 (de) 1993-12-22 1996-02-01 Schering Ag Zusammensetzung für die Empfängnisverhütung
DE19549264A1 (de) * 1995-12-23 1997-06-26 Schering Ag Verfahren und Kit zur Kontrazeption
WO2001030355A1 (fr) 1999-10-25 2001-05-03 Laboratoire Theramex Medicament contraceptif a base d'un progestatif et d'un estrogene et son mode de preparation
FR2754179B1 (fr) 1996-10-08 1998-12-24 Theramex Nouvelle composition hormononale et son utilisation
WO2001030356A1 (fr) * 1999-10-25 2001-05-03 Laboratoire Theramex Composition hormonale a base d'un progestatif et d'un estrogene et son utilisation
FR2814074B1 (fr) * 2000-09-15 2003-03-07 Theramex Nouvelles compositions estro-progestatives topiques a effet systemique
FR2823976A1 (fr) * 2001-04-25 2002-10-31 Theramex Nouvelle composition hormonale et son utilisation
UY29185A1 (es) * 2004-11-02 2006-05-31 Schering Ag Formas de dosificación oral sólidas que contienen una dosis baja de estradiol
PE20081895A1 (es) * 2007-03-26 2009-01-26 Theramex Regimen anticonceptivo oral
US20080293683A1 (en) * 2007-05-24 2008-11-27 University Of Kansas Medical Center Hormone Replacement Therapy
TW200930343A (en) * 2007-09-21 2009-07-16 Organon Nv Drug delivery system
US10596103B2 (en) 2013-12-11 2020-03-24 Merek Sharp & Dohme B.V. Drug delivery system for delivery of anti-virals
US10413504B2 (en) 2013-12-11 2019-09-17 Merck Sharp & Dohme Corp. Intravaginal ring drug delivery system
KR20240005348A (ko) 2022-07-05 2024-01-12 신규식 소멸특허 관리 및 특허거래 시스템

Family Cites Families (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3271392A (en) * 1965-09-14 1966-09-06 American Home Prod 17alpha-[3'-furyl]-estrogens
US4390531A (en) 1981-08-10 1983-06-28 Syntex Pharmaceuticals International Ltd. Method of contraception using peak progestogen dosage
US4921843A (en) 1988-10-20 1990-05-01 Pasquale Samuel A Contraception system and method
US4826831A (en) * 1983-08-05 1989-05-02 Pre Jay Holdings Limited Method of hormonal treatment for menopausal or post-menopausal disorders involving continuous administration of progestogens and estrogens
US4628051A (en) * 1983-09-26 1986-12-09 Ortho Pharmaceutical Corporation Triphasic oral contraceptive
JPS61243059A (ja) * 1985-04-19 1986-10-29 Konishi Kagaku Kogyo Kk 高純度４，４′−ジヒドロキシジフエニルスルホンの製造法
US5208225A (en) * 1986-02-27 1993-05-04 Warner-Lambert Company Compositions containing fixed combinations
ZA87332B (en) 1986-02-27 1987-08-26 Warner Lambert Co Compositions containing fixed combinations
IE61236B1 (en) 1986-07-15 1994-10-19 American Home Prod Combination dosage form for pre-menopausal women
US5276022A (en) * 1987-09-24 1994-01-04 Jencap Research Ltd. Hormone preparation and method
EP0309263B1 (en) 1987-09-24 1994-03-09 Jencap Research Limited Hormone composition and use
CA1332227C (en) 1987-09-24 1994-10-04 Robert F. Casper Oral contraceptive formulation
US5256421A (en) * 1987-09-24 1993-10-26 Jencap Research Ltd. Hormone preparation and method
US5108995A (en) * 1987-09-24 1992-04-28 Jencap Research Ltd. Hormone preparation and method
HUT52382A (en) 1988-03-14 1990-07-28 Sandoz Ag Process for producing pharmaceutical compositions comprising as active ingredient unsubstituted progestin in 19-position and estrogen in the given case
IE71203B1 (en) 1990-12-13 1997-02-12 Akzo Nv Low estrogen oral contraceptives
IE62665B1 (en) 1990-12-17 1995-02-22 Akzo Nv Contraceptive regimen
FR2695826B1 (fr) * 1992-09-21 1995-01-06 Theramex Nouvelles compositions pharmaceutiques à base de dérivés de nomégestrol et leurs procédés d'obtention.
US6150343A (en) 1993-06-30 2000-11-21 University Of Pittsburgh Camptothecin analogs and methods of preparation thereof
US5554601A (en) * 1993-11-05 1996-09-10 University Of Florida Methods for neuroprotection
DE4344462C2 (de) * 1993-12-22 1996-02-01 Schering Ag Zusammensetzung für die Empfängnisverhütung
US5552394A (en) * 1994-07-22 1996-09-03 The Medical College Of Hampton Roads Low dose oral contraceptives with less breakthrough bleeding and sustained efficacy
US6613757B1 (en) 1994-09-22 2003-09-02 Board Of Regents, The University Of Texas System Combination of prostacyclin with an estrogen or progestin for the prevention and treatment of atherosclerotic vascular disease including preeclampsia and for the treatment of hypertension, and for hormone replacement therapy
SE9403389D0 (sv) 1994-10-06 1994-10-06 Astra Ab Pharmaceutical composition containing derivattves of sex hormones
FR2737411B1 (fr) 1995-08-01 1997-10-17 Theramex Nouveaux medicaments hormonaux et leur utilisation pour la correction des carences estrogeniques
DE19540253C2 (de) 1995-10-28 1998-06-04 Jenapharm Gmbh Mehrphasenpräparat zur Kontrazeption auf der Basis natürlicher Estrogene
DE19549264A1 (de) 1995-12-23 1997-06-26 Schering Ag Verfahren und Kit zur Kontrazeption
AU2815897A (en) 1996-05-08 1997-11-26 American Home Products Corporation Oral contraceptive
WO1997041872A1 (en) 1996-05-08 1997-11-13 American Home Products Corporation Oral contraceptive
WO1997041871A1 (en) 1996-05-08 1997-11-13 American Home Products Corporation Oral contraceptive
WO1997041869A1 (en) 1996-05-08 1997-11-13 American Home Products Corporation Oral contraceptive
WO1997041870A1 (en) 1996-05-08 1997-11-13 American Home Products Corporation Oral contraceptive
WO1998004267A1 (en) 1996-07-26 1998-02-05 American Home Products Corporation Progestin/estrogen oral contraceptive
WO1998004246A2 (en) 1996-07-26 1998-02-05 American Home Prod Triphasic contraceptive method and kit comprising a combination of a progestin and estrogen
US5888543A (en) * 1996-07-26 1999-03-30 American Home Products Corporation Oral contraceptives
DK0917466T3 (da) 1996-07-26 2004-12-20 Wyeth Corp Oralt antikonceptionsmiddel
AU3961697A (en) 1996-07-26 1998-02-20 American Home Products Corporation Oral contraceptive
AU4043597A (en) 1996-07-26 1998-02-20 American Home Products Corporation Biphasic contraceptive method and kit comprising a combination of a progestin and estrogen
FR2754179B1 (fr) * 1996-10-08 1998-12-24 Theramex Nouvelle composition hormononale et son utilisation
WO2001030355A1 (fr) 1999-10-25 2001-05-03 Laboratoire Theramex Medicament contraceptif a base d'un progestatif et d'un estrogene et son mode de preparation
DE19705229C2 (de) 1997-02-12 1999-04-15 Hesch Rolf Dieter Prof Dr Med Verwendung von drei Hormonkomponenten zur hormonalen Kontrazeption zur Behandlung und/oder Prophylaxe von Tumoren der Brustdrüsen
US5898032A (en) 1997-06-23 1999-04-27 Medical College Of Hampton Roads Ultra low dose oral contraceptives with less menstrual bleeding and sustained efficacy
PT1007052E (pt) 1997-08-27 2005-01-31 Ortho Mcneil Pharm Inc Combinacoes de progestinas de crescimento do endometrico e progestinas de atropia do endometrio com estrogenios, em contracepcao oral
DE19739916C2 (de) 1997-09-11 2001-09-13 Hesch Rolf Dieter Verwendung einer Kombination aus einem Gestagen und einem Estrogen zur kontinuierlichen Ovulationshemmung und ggf. gleichzeitigen Behandlung und/oder Prophylaxe von Tumoren der Brustdrüsen
CN1270521A (zh) 1997-09-12 2000-10-18 美国家用产品公司 第一阶段包含孕激素/雌激素并且第二阶段包含孕激素的口服避孕制剂
WO2001030356A1 (fr) 1999-10-25 2001-05-03 Laboratoire Theramex Composition hormonale a base d'un progestatif et d'un estrogene et son utilisation

Also Published As

Publication number Publication date
AR073972A2 (es) 2010-12-15
PL192979B1 (pl) 2006-12-29
EP1334725A3 (fr) 2004-01-21
US20040220163A1 (en) 2004-11-04
NO991593L (no) 1999-06-07
ID21569A (id) 1999-06-24
SK285455B6 (sk) 2007-01-04
YU18099A (sh) 2002-03-18
NZ334876A (en) 2001-06-29
RU2274450C2 (ru) 2006-04-20
US7749987B2 (en) 2010-07-06
PT1334725E (pt) 2007-05-31
AP9901500A0 (en) 1999-06-30
SK43899A3 (en) 1999-12-10
DK1334725T3 (da) 2007-06-11
PL332610A1 (en) 1999-09-27
JP4883542B2 (ja) 2012-02-22
BR9712274A (pt) 1999-08-31
FR12C0005I2 (fr) 2016-06-24
CZ9901120A3 (cs) 2000-11-15
CN101229173A (zh) 2008-07-30
KR20060084864A (ko) 2006-07-25
ES2198006T3 (es) 2004-01-16
NO2017043I2 (no) 2019-01-25
MY128482A (en) 2007-02-28
FR12C0005I1 (fr) 2012-02-24
DE69737373D1 (de) 2007-03-29
DE69721314D1 (de) 2003-05-28
AU745571B2 (en) 2002-03-21
NO2012002I1 (no) 2012-01-24
TR199900764T2 (xx) 1999-07-21
OA11033A (fr) 2003-03-06
DE122012000010I1 (de) 2012-04-19
IL129194A0 (en) 2000-02-17
DK0956022T3 (da) 2003-08-04
HUP9904508A2 (hu) 2000-06-28
EP1334725B1 (fr) 2007-02-14
TW491704B (en) 2002-06-21
CZ298402B6 (cs) 2007-09-19
ATE353652T1 (de) 2007-03-15
KR20000048981A (ko) 2000-07-25
NO2017043I1 (no) 2017-08-08
AR009113A1 (es) 2000-03-08
HUS1200002I1 (hu) 2016-08-29
NO324357B1 (no) 2007-10-01
AP1171A (en) 2003-06-30
DZ2327A1 (fr) 2002-12-28
CA2268358A1 (fr) 1998-04-16
US6906049B1 (en) 2005-06-14
LU91932I9 (no) 2018-12-27
AU4627397A (en) 1998-05-05
DE69721314T2 (de) 2004-02-12
EP0956022A1 (fr) 1999-11-17
EP1334725A2 (fr) 2003-08-13
WO1998015279A1 (fr) 1998-04-16
DE69737373T2 (de) 2007-06-21
SK285056B6 (sk) 2006-05-04
FR2754179B1 (fr) 1998-12-24
NO2012002I2 (no) 2013-04-02
HUP9904508A3 (en) 2001-01-29
US6831073B1 (en) 2004-12-14
FR2754179A1 (fr) 1998-04-10
CL2011000017A1 (es) 2011-06-24
MA24370A1 (fr) 1998-07-01
CN104706641A (zh) 2015-06-17
KR100782638B1 (ko) 2007-12-06
EP0956022B1 (fr) 2003-04-23
TNSN97164A1 (fr) 1999-12-31
IL129194A (en) 2003-06-24
US20070281912A1 (en) 2007-12-06
CA2268358C (fr) 2010-04-20
LU91932I2 (fr) 2012-03-13
ES2282539T3 (es) 2007-10-16
JP2002509524A (ja) 2002-03-26
ATE238057T1 (de) 2003-05-15
PT956022E (pt) 2003-07-31
CN1239893A (zh) 1999-12-29
HK1210708A1 (en) 2016-05-06
ZA979011B (en) 1998-06-03
HU227450B1 (en) 2011-06-28

Similar Documents

Publication Publication Date Title
NO991593L (no) Hormonpreparat bestÕende av en °strogenforbindelse og en progesteronforbindelse
AU3008997A (en) Antagonists of gonadotropin releasing hormone
AU3922397A (en) Cementing slurry and method of designing a formulation
HU9900145D0 (en) Preparation of sterol and stanolesters
IS4385A (is) Stjórnuð losun stera úr sykruhúðum
AU2995599A (en) Topical compositions containing a combination of an antifungal agent and a steroidal antiinflammatory agent
EP0754036A4 (en) PERMANENTLY IONIC DERIVATIVES OF STEROID HORMONES AND THEIR ANTAGONISTS
AU3071397A (en) Antagonists of gonadotropin releasing hormone
AU3654697A (en) Transdermal application of naturally occurring steriod hormones
AU2601995A (en) Cementitious gypsum-containing compositions and materials made therefrom
AU3141197A (en) Antagonists of gonadotropin releasing hormone
EP0901471A4 (en) GONADOTROPIN RELEASING HORMONE ANTAGONISTS
PL320346A1 (en) Portland cement clinker and application thereof
AU5541298A (en) Steroid compounds having contraceptive and anti-osteoporosis activity
AU7468196A (en) Conjugates of gonadotropin releasing hormone
EP0754701A4 (en) NEW PROGESTERONE COMPOUND AND ITS USE
AU4825200A (en) Oral steroidal hormone compositions and methods of use
AU2749299A (en) Conversion and removal of steroid glycoalkaloids
AU6376398A (en) Sulfatation of estrogen mixtures
AU1000997A (en) Cementitious gypsum-containing compositions and materials made therefrom
GB9602951D0 (en) Conjugates of gonadotropin releasing hormone
AU3105997A (en) Internal and external building material
GB9606017D0 (en) Manufacture of steroids
AU2002306305A1 (en) Derivatives of growth hormone and related proteins
ZA974072B (en) Stabilized thyroid hormone preparations and methods of making same

Legal Events

Date Code Title Description
SPCF Filing of supplementary protection certificate

Free format text: PRODUCT NAME: ZOELY - NOMEGESTROLACETAT/OESTRADIOL; NAT. REG. NO/DATE: (92) DATO FOR SAMME: 2011.07.27 20110727; FIRST REG. NO/DATE: (93) DATO FOR SAMME: 2011.07.27 20110727

Spc suppl protection certif: 2012002

Filing date: 20120124

SPCG Granted supplementary protection certificate

Free format text: PRODUCT NAME: ZOELY - NOMEGESTROLACETAT/OESTRADIOL; REG. NO/DATE: EU/1/11/690/001-002 20110727

Spc suppl protection certif: 2012002

Filing date: 20120124

Extension date: 20221008

SPCE Application to extend a supplementary protection certificate (spc)

Free format text: PRODUCT NAME: NOMEGESTROLACETAT + FRITT ELLER ESTERIFISERT OESTRADIOL; REG. NO/DATE: EU/1/11/690/001-002 20110727

Spc suppl protection certif: 2017043

Filing date: 20170808

MK1K Patent expired
SPCH Extension of a supplementary protection certificate (spc) granted

Free format text: PRODUCT NAME: NOMEGESTROLACETAT + FRITT ELLER ESTERIFISERT OESTRADIOL; REG. NO/DATE: EU/1/11/690/001-002 20110727

Spc suppl protection certif: 2017043

Filing date: 20170808

Extension date: 20230408

SPCS Change of name or address of the owner of a supplementary protection certificate

Owner name: THERAMEX HQ UK LIMITED, MC

Spc suppl protection certif: 2017043

Owner name: THERAMEX HQ UK LIMITED, MC

Spc suppl protection certif: 2012002

SPCX Expiry of an spc

Spc suppl protection certif: 2017043

Expiry date: 20230504